Replies to post #203902 on Biotech Values

[BiotechValues]

Phillip Frost owns 15% of MBVX so (hopefully) he's right on this one.

Looking forward to the Phase I update. Having lost close family members to pancreatic cancer, I'm hopeful their immuno-oncology research turns out to bring some positives- either in treatment or imaging improvements.